Community Health Systems, Inc.

Q2 2026 Adjusted EBITDA was $330 million, down from $380 million in the prior-year period; margin was 11.7% versus 12.1%. Net revenue declined 9.8% year over year. Same-store net revenue increased 2.4%, same-store inpatient admissions rose 1.9%, and same-store adjusted admissions increased 2.9%, while same-store net revenue per adjusted admission declined 0.5%. Cash flows from operations were $87 million, or $143 million adjusted to exclude cash taxes paid out of divestiture proceeds. Full-year 2026 guidance was reduced to net revenue of $11.4 billion-$11.6 billion and Adjusted EBITDA of $1.3 billion-$1.375 billion. Management said the revision reflects full-year benefits from Medicaid state-directed payment programs in Georgia, Indiana, and Florida, partly offset by macro headwinds, ACA disenrollment, and continued softness in elective surgery volumes.

Kevin Hammons emphasized operational progress despite a tough operating backdrop, citing better quality, physician experience, patient experience, and employee satisfaction metrics. He highlighted recognition such as Leapfrog grades and hospital awards, arguing these improvements should support long-term financial performance. On the quarter, he said the company is seeing temporary demand disruption tied to consumer insecurity, inflation, and geopolitical instability, but noted improving volume and surgical trends exiting the quarter.

Jason Johnson said results were below internal expectations but that controllable execution remained strong, including cost control and sequential volume improvement. He cited $330 million of Adjusted EBITDA, an 11.7% margin, and approximately $40 million-$45 million of EBITDA contribution from Florida and Indiana state-directed payment programs, partly offset by about $15 million from an Arizona true-up. He also noted cash from operations of $87 million, leverage of 6.7x, no ABL borrowings, and that the company repurchased about $368 million of 4.75% 2031 notes and $231 million of 10.875% 2032 notes using divestiture proceeds.

Analysts focused on the ACA exchange disenrollment impact, surgical softness, cash flow, and medical specialist fees. Management said HIX disenrollment is now expected to have a $50 million-$75 million annual impact, with much of the lost exchange volume showing up as self-pay; they also said cash flow pressure is being driven by slower payer payments, more claim audits, and higher AR days rather than a collection problem. On surgeries, management said the weakness is concentrated in more elective procedures like orthopedics and some cardiac cases, with outpatient and surgery-center activity holding up better than inpatient surgery.